Jonathan Feistmann, MD
Ophthalmology · New York, NYNPI 1447331087
Payments from drug & device makers
Across 116 payments — averaging $433.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$33K
- Carl Zeiss Meditec USA, Inc.$5K
- Alcon Research LLC$5K
- Alcon$2K
- Apellis Pharmaceuticals, Inc.$2K
- Regeneron Healthcare Solutions, Inc.$2K
- plus $2K from 10 others
What the payments were for
- Consulting fees$30,72367%
- Speaking & faculty fees$5,75013%
- Travel & lodging$2,3065%
- Food & beverage$3,5198%
- Gifts$190%
- Entertainment$340%
- Other$3,2657%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 12 | $32,980 |
| Carl Zeiss Meditec USA, Inc. | 6 | $4,853 |
| Alcon Research LLC | 3 | $4,650 |
| Alcon | 9 | $2,368 |
| Apellis Pharmaceuticals, Inc. | 7 | $1,816 |
| Regeneron Healthcare Solutions, Inc. | 53 | $1,571 |
| Onmark, Inc. | 9 | $1,440 |
| Mallinckrodt Hospital Products Inc. | 3 | $251 |
| Astellas Pharma US Inc | 3 | $95 |
| Genentech USA, Inc. | 3 | $72 |
| Eyepoint US, Inc. | 2 | $45 |
| Optos, Inc. | 2 | $34 |
| Regeneron | 1 | $34 |
| Bausch & Lomb Americas Inc. | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| US Oncology Corporate, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CLARUS$11,050
- CIRRUS HD-OCT$10,439
- FORUM$8,688
- Humphrey HFA$6,988
- FORUM Glaucoma Workplace$4,250
- Retina Workplace$4,250
- ARTEVO 800$3,265
- CIRRUS 6000 with AngioPlex$2,975
- Humphrey Field Analyzer (HFA3)$2,550
- Unity$2,183
- IOLMaster 700$1,514
- VERACITY SURGICAL$1,514
- VisuMax$1,514
- QUATERA 700$425
- CALLISTO eye$425
- EYLEA HD$368
- EYLEA$254
- ACTHAR$237
- Clareon PanOptix Pro$104
How this compares
$50,267 in reported general payments places this provider in the 90th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProlensaBromfenac Sodium | 37 | $15,893 |
| Bromfenac Sodium | 48 | $6,320 |
| Prednisolone Acetate | 98 | $5,265 |
| Difluprednate | 22 | $1,329 |
| Ofloxacin | 39 | $800 |
| Latanoprost | 116 | $674 |
| Ketorolac Tromethamine | 24 | $503 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 34 | $411 |
| Dorzolamide Hcl | 23 | $311 |
| Brimonidine Tartrate | 24 | $240 |
| Timolol Maleate | 16 | $172 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in New York
- Douglas JabsNew York$24.3M
- Nathan RadcliffeNew York$2.4M
- Richard SpaideNew York$1.7M
- Jason SlakterNew York$1.2M
- David ChuNew York$1.2M
- Sharon KehNew York$941K
- Joshua YoungNew York$814K
- Joseph PanarelliNew York$704K
- Joshua KimNew York$677K
- Eric RosenbergNew York$526K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.